Abstract: The present invention is directed to novel pyrrolidine carboxylic acid derivatives, pharmaceutical compositions, and their use in treating and/or preventing metabolic diseases as agonists of g-protein coupled receptor 43.
Type:
Grant
Filed:
June 18, 2012
Date of Patent:
July 4, 2017
Assignee:
Ogeda SA
Inventors:
Hamid R. Hoveyda, Didier Schils, Ludivine Zoute, Julien Parcq